Product Data Sheet

Gardiquimod

Catalog No. A35269

main product photo
Gardiquimod is an imidazoline compound that acts as an agonist for Toll-like receptors 7 and 8 (TLR7/8). This reagent has been shown to inhibit HIV-1 infection in macrophages and activated peripheral blood mononuclear cells (PBMCs). Gardiquimod specifically activates TLR7 at concentrations below 10 μM, making it a valuable tool in immunological research and studies related to viral infections.
Chemical Information
Catalog NumA35269
M. Wt313.40
FormulaC17H23N5O
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.1020412-43-4
Synonyms
SMILESOC(C)(C)CN1C(CNCC)=NC2=C1C3=CC=CC=C3N=C2N
Biological Activity
DescriptionGardiquimod is an imidazoline compound that acts as an agonist for Toll-like receptors 7 and 8 (TLR7/8). This reagent has been shown to inhibit HIV-1 infection in macrophages and activated peripheral blood mononuclear cells (PBMCs). Gardiquimod specifically activates TLR7 at concentrations below 10 μM, making it a valuable tool in immunological research and studies related to viral infections.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.